Correlation Between Diamyd Medical and Coca-Cola FEMSA

Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and Coca-Cola FEMSA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and Coca-Cola FEMSA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diamyd Medical AB and Coca Cola FEMSA SAB, you can compare the effects of market volatilities on Diamyd Medical and Coca-Cola FEMSA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of Coca-Cola FEMSA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and Coca-Cola FEMSA.

Diversification Opportunities for Diamyd Medical and Coca-Cola FEMSA

0.27

Correlation Coefficient

Diamyd Medical  Coca-Cola FEMSA

Modest diversification

The 3 months correlation between Diamyd and Coca-Cola is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and Coca Cola FEMSA SAB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coca Cola FEMSA and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with Coca-Cola FEMSA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coca Cola FEMSA has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and Coca-Cola FEMSA go up and down completely randomly.

Pair Corralation between Diamyd Medical and Coca-Cola FEMSA

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 3.36 times more return on investment than Coca-Cola FEMSA. However, Diamyd Medical is 3.36 times more volatile than Coca Cola FEMSA SAB. It trades about 0.14 of its potential returns per unit of risk. Coca Cola FEMSA SAB is currently generating about -0.3 per unit of risk. If you would invest  135.00  in Diamyd Medical AB on October 10, 2024 and sell it today you would earn a total of  10.00  from holding Diamyd Medical AB or generate 7.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Diamyd Medical AB  vs.  Coca Cola FEMSA SAB

Diamyd Medical AB

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Coca Cola FEMSA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Coca Cola FEMSA SAB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Diamyd Medical and Coca-Cola FEMSA

The main advantage of trading using opposite Diamyd Medical and Coca-Cola FEMSA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, Coca-Cola FEMSA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coca-Cola FEMSA will offset losses from the drop in Coca-Cola FEMSA's long position.

The idea behind Diamyd Medical AB and Coca Cola FEMSA SAB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.